index - Thérapie génique pour la DMD & physiopathologie du muscle squelettique Accéder directement au contenu

Dernières publications

Chiffres clés

48 Publications avec texte intégral

Open Access

67 %

Mots clés

Dynamin 2 Delivery Multiresolution modeling Muscular dystrophy Hear Centronuclear myopathy NAD+ LncRNA Muscle Strength Dystrophy Homeostasis Becker muscular dystrophy BMD Gene modifiers Epigenetics Mitochondrial fission Becker muscular dystrophy Ex-vivo Cell Biology Becker muscular dystrophy BMD Duchenne muscular dystrophy DMD miRNA nNOS Drp1 Multi exon skipping Clinical trials DMO Human Umbilical Vein Endothelial Cells Genomic CaV subunits Multi resolution modeling Muscle development Mdx mouse Myogenesis Autophagy Metabolism Duchenne DMD dystrophy Male MES Skeletal muscle Inhibitors Muscle Cardiomyopathy Muscular Dystrophy Cells Inbred mdx Dystrophie Musculaire de Becker BMD Antisense oligonucleotides DMD Hepatocellular carcinoma Molecular docking Humans Long QT Myotendinous junction Becker BMD muscular dystrophy Liver Duchenne muscular dystrophy CTNNB1 Energy Metabolism/drug effects CD38 L-Type BMD Mice Exon skipping NNOS DHPR α1S Dystrophine Morphogenesis Muscular Atrophy Animal/physiopathology Cell Line Inbred C57BL Calcium Génomique Cardiomyopathie Cell homeostasis MiARN Animals Dystrophie Musculaire de Duchenne DMD Gene Expression Regulation/drug effects CaVβs Long noncoding RNA Base Sequence Diseases Dystrophin-EGFP Cultured LKB1 Calcium Channels Muscles/physiopathology Gene expression Dystrophin Duchenne muscular dystrophy DMD Allele‐specific silencing therapy Modificateurs de gènes Muscle Biology Molecular Sequence Data Dystrophin central domain Invivo Dystrophie musculaire de Becker LncARN Activin Receptors Cachexia Immunoglobulin Fc Fragments/pharmacology Knockout